The Steering Committee members of ADVANCE meet Dr Michel Goldman at the ADVANCE Bootcamp to shape the post-project phase


ADVANCE organised a Bootcamp in Leuven (Belgium) on January 24th-26th to discuss the sustainability of the project. During three days the ADVANCE Steering Committee exchanged views and outlined a hub/platform model for the sustainability phase.

The former of the Innovative Medicines Initiative (IMI) director - Dr. Michel Goldman - attended the last day of the Bootcamp and provided insights on the strategy for the future of ADVANCE. This Bootcamp was a unique opportunity to exchange ideas and concerns about how public and private partners could interact and participate in a future sustainable framework for vaccine benefit risk monitoring.